-
Something wrong with this record ?
Detailed molecular characterization of a novel IDS exonic mutation associated with multiple pseudoexon activation
L. Grodecká, T. Kováčová, M. Kramárek, S. Seneca, K. Stouffs, C. De Laet, F. Majer, T. Kršjaková, P. Hujová, K. Hrnčířová, P. Souček, W. Lissens, E. Buratti, T. Freiberger,
Language English Country Germany
Document type Case Reports, Journal Article
Grant support
NV15-33297A
MZ0
CEP Register
NV16-34414A
MZ0
CEP Register
Digital library NLK
Full text - Article
Full text - Article
Source
NLK
ProQuest Central
from 1997-01-01 to 1 year ago
Medline Complete (EBSCOhost)
from 2000-01-01 to 1 year ago
Health & Medicine (ProQuest)
from 1997-01-01 to 1 year ago
- MeSH
- Point Mutation MeSH
- Exons MeSH
- Glycoproteins genetics MeSH
- Introns MeSH
- Humans MeSH
- RNA, Messenger genetics MeSH
- RNA Splice Sites MeSH
- Adolescent MeSH
- Mucopolysaccharidosis II genetics MeSH
- Mutation MeSH
- RNA Splicing MeSH
- Check Tag
- Humans MeSH
- Adolescent MeSH
- Male MeSH
- Publication type
- Journal Article MeSH
- Case Reports MeSH
Mutations affecting splicing underlie the development of many human genetic diseases, but rather rarely through mechanisms of pseudoexon activation. Here, we describe a novel c.1092T>A mutation in the iduronate-2-sulfatase (IDS) gene detected in a patient with significantly decreased IDS activity and a clinical diagnosis of mild mucopolysaccharidosis II form. The mutation created an exonic de novo acceptor splice site and resulted in a complex splicing pattern with multiple pseudoexon activation in the patient's fibroblasts. Using an extensive series of minigene splicing experiments, we showed that the competition itself between the de novo and authentic splice site led to the bypass of the authentic one. This event then resulted in activation of several cryptic acceptor and donor sites in the upstream intron. As this was an unexpected and previously unreported mechanism of aberrant pseudoexon inclusion, we systematically analysed and disproved that the patient's mutation induced any relevant change in surrounding splicing regulatory elements. Interestingly, all pseudoexons included in the mature transcripts overlapped with the IDS alternative terminal exon 7b suggesting that this sequence represents a key element in the IDS pre-mRNA architecture. These findings extend the spectrum of mechanisms enabling pseudoexon activation and underscore the complexity of mutation-induced splicing aberrations. KEY MESSAGE: Novel exonic IDS gene mutation leads to a complex splicing pattern. Mutation activates multiple pseudoexons through a previously unreported mechanism. Multiple cryptic splice site (ss) activation results from a bypass of authentic ss. Authentic ss bypass is due to a competition between de novo and authentic ss.
Center for Medical Genetics UZ Brussel and Vrije Universiteit Brussel 1090 Brussels Belgium
Central European Institute of Technology Masaryk University Brno Czech Republic
International Centre for Genetic Engineering and Biotechnology Trieste Italy
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18010946
- 003
- CZ-PrNML
- 005
- 20201112211813.0
- 007
- ta
- 008
- 180404s2017 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00109-016-1484-2 $2 doi
- 035 __
- $a (PubMed)27837218
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Grodecká, L $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic. Molecular Genetics Laboratory, Centre for Cardiovascular Surgery and Transplantation, Pekařská 53, 656 91, Brno, Czech Republic.
- 245 10
- $a Detailed molecular characterization of a novel IDS exonic mutation associated with multiple pseudoexon activation / $c L. Grodecká, T. Kováčová, M. Kramárek, S. Seneca, K. Stouffs, C. De Laet, F. Majer, T. Kršjaková, P. Hujová, K. Hrnčířová, P. Souček, W. Lissens, E. Buratti, T. Freiberger,
- 520 9_
- $a Mutations affecting splicing underlie the development of many human genetic diseases, but rather rarely through mechanisms of pseudoexon activation. Here, we describe a novel c.1092T>A mutation in the iduronate-2-sulfatase (IDS) gene detected in a patient with significantly decreased IDS activity and a clinical diagnosis of mild mucopolysaccharidosis II form. The mutation created an exonic de novo acceptor splice site and resulted in a complex splicing pattern with multiple pseudoexon activation in the patient's fibroblasts. Using an extensive series of minigene splicing experiments, we showed that the competition itself between the de novo and authentic splice site led to the bypass of the authentic one. This event then resulted in activation of several cryptic acceptor and donor sites in the upstream intron. As this was an unexpected and previously unreported mechanism of aberrant pseudoexon inclusion, we systematically analysed and disproved that the patient's mutation induced any relevant change in surrounding splicing regulatory elements. Interestingly, all pseudoexons included in the mature transcripts overlapped with the IDS alternative terminal exon 7b suggesting that this sequence represents a key element in the IDS pre-mRNA architecture. These findings extend the spectrum of mechanisms enabling pseudoexon activation and underscore the complexity of mutation-induced splicing aberrations. KEY MESSAGE: Novel exonic IDS gene mutation leads to a complex splicing pattern. Mutation activates multiple pseudoexons through a previously unreported mechanism. Multiple cryptic splice site (ss) activation results from a bypass of authentic ss. Authentic ss bypass is due to a competition between de novo and authentic ss.
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a exony $7 D005091
- 650 _2
- $a glykoproteiny $x genetika $7 D006023
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a introny $7 D007438
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a mukopolysacharidóza II $x genetika $7 D016532
- 650 _2
- $a mutace $7 D009154
- 650 _2
- $a bodová mutace $7 D017354
- 650 _2
- $a místa sestřihu RNA $7 D022821
- 650 _2
- $a sestřih RNA $7 D012326
- 650 _2
- $a messenger RNA $x genetika $7 D012333
- 655 _2
- $a kazuistiky $7 D002363
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kováčová, T $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic. Molecular Genetics Laboratory, Centre for Cardiovascular Surgery and Transplantation, Pekařská 53, 656 91, Brno, Czech Republic.
- 700 1_
- $a Kramárek, M $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Seneca, S $u Center for Medical Genetics, UZ Brussel and Vrije Universiteit Brussel, 1090, Brussels, Belgium.
- 700 1_
- $a Stouffs, K $u Center for Medical Genetics, UZ Brussel and Vrije Universiteit Brussel, 1090, Brussels, Belgium.
- 700 1_
- $a De Laet, C $u Nutrition and Metabolism Unit, University Children's Hospital Queen Fabiola, Free University of Brussels (ULB), 1020, Brussels, Belgium.
- 700 1_
- $a Majer, F $u Institute of Inherited Metabolic Disorders, First Faculty of Medicine, Charles University, Prague, Czech Republic.
- 700 1_
- $a Kršjaková, T $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Hujová, P $u Molecular Genetics Laboratory, Centre for Cardiovascular Surgery and Transplantation, Pekařská 53, 656 91, Brno, Czech Republic.
- 700 1_
- $a Hrnčířová, K $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Souček, P $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Lissens, W $u Center for Medical Genetics, UZ Brussel and Vrije Universiteit Brussel, 1090, Brussels, Belgium.
- 700 1_
- $a Buratti, E $u International Centre for Genetic Engineering and Biotechnology, Trieste, Italy.
- 700 1_
- $a Freiberger, Tomas $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic. tomas.freiberger@cktch.cz. Molecular Genetics Laboratory, Centre for Cardiovascular Surgery and Transplantation, Pekařská 53, 656 91, Brno, Czech Republic. tomas.freiberger@cktch.cz. Institute of Clinical Immunology and Allergology, St. Anne's University Hospital and Masaryk University, Brno, Czech Republic. tomas.freiberger@cktch.cz.
- 773 0_
- $w MED00002812 $t Journal of molecular medicine (Berlin, Germany) $x 1432-1440 $g Roč. 95, č. 3 (2017), s. 299-309
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27837218 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180404 $b ABA008
- 991 __
- $a 20201112211809 $b ABA008
- 999 __
- $a ok $b bmc $g 1288431 $s 1007758
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 95 $c 3 $d 299-309 $e 20161112 $i 1432-1440 $m Journal of molecular medicine $n J Mol Med $x MED00002812
- GRA __
- $a NV15-33297A $p MZ0
- GRA __
- $a NV16-34414A $p MZ0
- LZP __
- $a Pubmed-20180404